serw-MX  [xml]  

 DeCS Categories

D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.486 Immunoproteins .
D12.776.124.486.485 Immunoglobulins .
D12.776.124.486.485.114 Antibodies .
D12.776.124.486.485.114.224 Antibodies, Monoclonal .
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized .
D12.776.124.486.485. Ranibizumab .
D12.776.124.790 Serum Globulins .
D12.776.124.790.651 Immunoglobulins .
D12.776.124.790.651.114 Antibodies .
D12.776.124.790.651.114.224 Antibodies, Monoclonal .
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized .
D12.776.124.790.651. Ranibizumab .
D12.776.377 Globulins .
D12.776.377.715 Serum Globulins .
D12.776.377.715.548 Immunoglobulins .
D12.776.377.715.548.114 Antibodies .
D12.776.377.715.548.114.224 Antibodies, Monoclonal .
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized .
D12.776.377.715.548. Ranibizumab .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.695 Receptors, G-Protein-Coupled .
D12.776.543.750.695.900 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.695.910 Receptors, Vasopressin .
D12.776.543.750.720 Receptors, Neurotransmitter .
D12.776.543.750.720.600 Receptors, Neuropeptide .
D12.776.543.750.720.600.915 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.720.600.925 Receptors, Vasopressin .
D12.776.543.750.750 Receptors, Peptide .
D12.776.543.750.750.360 Receptors, Gastrointestinal Hormone .
D12.776.543.750.750.360.900 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.750.555 Receptors, Neuropeptide .
D12.776.543.750.750.555.915 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.750.555.925 Receptors, Vasopressin .
D12.776.543.750.750.660 Receptors, Pituitary Hormone .
D12.776.543.750.750.660.900 Receptors, Vasopressin .
D12.776.543.750.830 Receptors, Virus .
 Synonyms & Historicals
Receptors, Vasopressin .
8-Arg-Vasopressin Receptor .
Antidiuretic Hormone Receptor .
Antidiuretic Hormone Receptor 1a .
Antidiuretic Hormone Receptor 1b .
Arginine Vasopressin Receptor .
Argipressin Receptor .
Argipressin Receptors .
Receptor, Arginine(8)-Vasopressin .
Renal-Type Arginine Vasopressin Receptor .
V1 Receptor .
V1a Vasopressin Receptor .
V1b Vasopressin Receptor .
V2 Receptor .
Vascular-Hepatic Type Arginine Vasopressin Receptor .
Vasopressin Receptor .
Vasopressin Receptor 1 .
Vasopressin Type 1A Receptor .
Vasopressin V1a Receptor .
Vasopressin V1b Receptor .
Vasopressin V2 Receptor .
Vasopressin V3 Receptor .
8 Arg Vasopressin Receptor .
Hormone Receptor, Antidiuretic .
Hormone Receptors, Antidiuretic .
Receptor, Antidiuretic Hormone .
Receptor, Arginine Vasopressin .
Receptor, Argipressin .
Receptor, V1 .
Receptor, V2 .
Receptor, Vasopressin .
Receptor, Vasopressin V1b .
Receptor, Vasopressin V3 .
Receptors, Antidiuretic Hormone .
Receptors, Argipressin .
Renal Type Arginine Vasopressin Receptor .
V1b Receptor, Vasopressin .
Vascular Hepatic Type Arginine Vasopressin Receptor .
Vasopressin Receptor, V1b .
Antidiuretic Hormone Receptors .
Receptors, V1 .
Receptors, V2 .
Vasopressin Receptors .
V1 Receptors .
V2 Receptors .
Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors. .
Receptors, Virus .
Receptors, Phage .
Phage Receptors .
Virus Receptors .
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. .
Receptors, Vasoactive Intestinal Peptide .
VIP Receptor .
Vasoactive Intestinal Peptide Receptor .
Receptor, VIP .
Receptors, VIP .
Vasoactive Intestinal Peptide Receptors .
VIP Receptors .
Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; (VIP); with high affinity and trigger intracellular changes which influence the behavior of cells. .
Ranibizumab .
Lucentis .
RhuFab V2 .
V2, RhuFab .
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION. .